# US 2020/0002708 A1 · Tobacco plant and production method thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0002708 A1
- Document ID: US20200002708A1
- Status: Published application
- Kind: A1
- Application number: 16/569,326
- Filed: 2019-09-12
- Published: 2020-01-02
- Earliest claimed: 2017-03-16
- Assignees: Japan Tobacco Inc.
- Applicants: Japan Tobacco Inc.
- Inventors: Shoichi SUZUKI; Kaori HAMANO; Ayako NOMURA; Mai TSUKAHARA
- Web page: https://patentgrep.com/patent/US20200002708A1

## CPC

- C12N 15/8262: {involving plant development}
- C12N 15/827: {Flower development or morphology, e.g. flowering promoting factor [FPF]}
- A01H 5/12: Leaves
- A01H 6/823: {Nicotiana, e.g. tobacco}
- A24B 15/00: Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form (A24B3/00 takes precedence)
- C07K 14/415: from plants
- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C12N 15/8218: {Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]}
- C12Q 1/6895: for plants, fungi or algae
- C12Q 2600/13: Plant traits
- C12Q 2600/156: Polymorphic or mutational markers
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A01H: NEW PLANTS OR {NON-TRANSGENIC} PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A24B: MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Provided are (i) a tobacco plant which is suitable for cultivation for harvesting leaf tobaccos, (ii) a method of obtaining the tobacco plant, (iii) a harvest from the tobacco plant, and (iv) a processed product of the harvest. The present invention encompasses (i) a tobacco plant into which a mutation for suppressing the development of primary axillary buds is introduced, (ii) a method of obtaining the tobacco plant, (iii) a harvest from the tobacco plant, and (iv) a processed product of the harvest.

## Claims

### Claim 1

A tobacco plant in which a mutation causing functional suppression of at least two genes of the following genes (1) through (3) is introduced into a genome:
(1) at least one of: a gene containing, as a coding region, a polynucleotide (a) or a polynucleotide (b); and a gene containing, as a coding region, a polynucleotide (c) or a polynucleotide (d);
(2) at least one of: a gene containing, as a coding region, a polynucleotide (e) or a polynucleotide (f); and a gene containing, as a coding region, a polynucleotide (g) or a polynucleotide (h); and
(3) at least one of: a gene containing, as a coding region, a polynucleotide (i) or a polynucleotide (j); and a gene containing, as a coding region, a polynucleotide (k) or a polynucleotide (l),
the functional suppression suppressing development of primary axillary buds,
the polynucleotide (a) being a polynucleotide encoding a polypeptide having a sequence identity of 90% or higher with an amino acid sequence represented by SEQ ID NO: 1,
the polynucleotide (b) being a polynucleotide complementary to a polynucleotide which hybridizes with the polynucleotide (a) under stringent conditions,
the polynucleotide (c) being a polynucleotide encoding a polypeptide having a sequence identity of 90% or higher with an amino acid sequence represented by SEQ ID NO: 2,
the polynucleotide (d) being a polynucleotide complementary to a polynucleotide which hybridizes with the polynucleotide (c) under stringent conditions,
the polynucleotide (e) being a polynucleotide encoding a polypeptide having a sequence identity of 90% or higher with an amino acid sequence represented by SEQ ID NO: 3,
the polynucleotide (f) being a polynucleotide complementary to a polynucleotide which hybridizes with the polynucleotide (e) under stringent conditions,
the polynucleotide (g) being a polynucleotide encoding a polypeptide having a sequence identity of 90% or higher with an amino acid sequence represented by SEQ ID NO: 4,
the polynucleotide (h) being a polynucleotide complementary to a polynucleotide which hybridizes with the polynucleotide (g) under stringent conditions,
the polynucleotide (i) being a polynucleotide encoding a polypeptide having a sequence identity of 90% or higher with an amino acid sequence represented by SEQ ID NO: 5,
the polynucleotide (j) being a polynucleotide complementary to a polynucleotide which hybridizes with the polynucleotide (i) under stringent conditions,
the polynucleotide (k) being a polynucleotide encoding a polypeptide having a sequence identity of 90% or higher with an amino acid sequence represented by SEQ ID NO: 6, and
the polynucleotide (l) being a polynucleotide complementary to a polynucleotide which hybridizes with the polynucleotide (k) under stringent conditions.

### Claim 2 (depends on 1)

The tobacco plant according to claim 1, wherein the functional suppression causes the number or weight of the primary axillary buds to decrease to not more than ½ of that of a wild-type plant.

### Claim 3 (depends on 1)

The tobacco plant according to claim 1, wherein the functional suppression is a decrease, as compared with a wild-type plant, in abundance of polypeptides which are expression products of the at least two genes.

### Claim 4 (depends on 3)

The tobacco plant according to claim 3, wherein the functional suppression is a decrease, as compared with a wild-type plant, in an amount of translation of the polypeptides which are expression products of the at least two genes.

### Claim 5 (depends on 3)

The tobacco plant according to claim 3, wherein the functional suppression is a decrease, as compared with a wild-type plant, in an amount of transcription from the at least two genes to mRNA.

### Claim 6 (depends on 3)

The tobacco plant according to claim 3, wherein the functional suppression is promotion of degradation of mRNAs transcribed from the at least two genes.

### Claim 7 (depends on 1)

The tobacco plant according to claim 1, wherein the mutation is introduced into each of the at least two genes.

### Claim 8 (depends on 7)

The tobacco plant according to claim 7, wherein the mutation is introduced by spontaneous mutation, mutagen treatment, gene recombination, genome editing, or gene knockout.

### Claim 9 (depends on 6)

The tobacco plant according to claim 6, wherein the mutation is insertion, into an outside of a region in which the at least two genes are present, of a polynucleotide expressing a factor which promotes the degradation of the mRNA.

### Claim 10 (depends on 9)

The tobacco plant according to claim 9, wherein the factor is an antisense RNA molecule, an RNAi molecule, or a co-suppression molecule.

### Claim 11 (depends on 1)

The tobacco plant according to claim 1, wherein the tobacco plant belongs to Nicotiana tabacum or Nicotiana rustica.

### Claim 12

A method of producing a tobacco plant, comprising the step of:
(A) introducing, into a genome of a tobacco plant, a mutation causing functional suppression of at least two genes of the following genes (1) through (3):
(1) at least one of: a gene containing, as a coding region, a polynucleotide (a) or a polynucleotide (b); and a gene containing, as a coding region, a polynucleotide (c) or a polynucleotide (d);
(2) at least one of: a gene containing, as a coding region, a polynucleotide (e) or a polynucleotide (f); and a gene containing, as a coding region, a polynucleotide (g) or a polynucleotide (h); and
(3) at least one of: a gene containing, as a coding region, a polynucleotide (i) or a polynucleotide (j); and a gene containing, as a coding region, a polynucleotide (k) or a polynucleotide (l),
the functional suppression suppressing development of primary axillary buds,
the polynucleotide (a) being a polynucleotide encoding a polypeptide having a sequence identity of 90% or higher with an amino acid sequence represented by SEQ ID NO: 1,
the polynucleotide (b) being a polynucleotide complementary to a polynucleotide which hybridizes with the polynucleotide (a) under stringent conditions,
the polynucleotide (c) being a polynucleotide encoding a polypeptide having a sequence identity of 90% or higher with an amino acid sequence represented by SEQ ID NO: 2,
the polynucleotide (d) being a polynucleotide complementary to a polynucleotide which hybridizes with the polynucleotide (c) under stringent conditions,
the polynucleotide (e) being a polynucleotide encoding a polypeptide having a sequence identity of 90% or higher with an amino acid sequence represented by SEQ ID NO: 3,
the polynucleotide (f) being a polynucleotide complementary to a polynucleotide which hybridizes with the polynucleotide (e) under stringent conditions,
the polynucleotide (g) being a polynucleotide encoding a polypeptide having a sequence identity of 90% or higher with an amino acid sequence represented by SEQ ID NO: 4,
the polynucleotide (h) being a polynucleotide complementary to a polynucleotide which hybridizes with the polynucleotide (g) under stringent conditions,
the polynucleotide (i) being a polynucleotide encoding a polypeptide having a sequence identity of 90% or higher with an amino acid sequence represented by SEQ ID NO: 5,
the polynucleotide (j) being a polynucleotide complementary to a polynucleotide which hybridizes with the polynucleotide (i) under stringent conditions,
the polynucleotide (k) being a polynucleotide encoding a polypeptide having a sequence identity of 90% or higher with an amino acid sequence represented by SEQ ID NO: 6, and
the polynucleotide (l) being a polynucleotide complementary to a polynucleotide which hybridizes with the polynucleotide (k) under stringent conditions.

### Claim 13 (depends on 12)

The method according to claim 12, further comprising the step of:
(B) selecting, from individuals produced by the step (A), an individual in which development of the primary axillary buds is suppressed.

### Claim 14 (depends on 13)

The method according to claim 13, wherein in the step (B), an individual, in which the number or weight of the primary axillary buds is decreased in comparison with that of a wild-type plant, is selected.

### Claim 15 (depends on 12)

The method according to claim 12, wherein the step (A) includes introducing the mutation into each of the at least two genes.

### Claim 16 (depends on 15)

The method according to claim 15, wherein the step (A) is carried out by spontaneous mutation, mutagen treatment, gene recombination, genome editing, or gene knockout.

### Claim 17 (depends on 12)

The method according to claim 12, wherein the step (A) includes inserting, into an outside of a region in which the at least two genes are present, a polynucleotide expressing a factor which promotes the degradation of the mRNAs transcribed from the at least two genes.

### Claim 18 (depends on 17)

The method according to claim 17, wherein the factor is an antisense RNA molecule, an RNAi molecule, or a co-suppression molecule.

### Claim 19

A method of determining a tobacco plant in which development of primary axillary buds is suppressed, the method comprising the steps of:
(A) obtaining a sample by collecting a part of a tobacco plant;
(B) detecting, from a genome included in the sample, a mutation causing functional suppression of at least two genes of the following genes (1) through (3) on the genome:
(1) at least one of: a gene containing, as a coding region, a polynucleotide (a) or a polynucleotide (b); and a gene containing, as a coding region, a polynucleotide (c) or a polynucleotide (d);
(2) at least one of: a gene containing, as a coding region, a polynucleotide (e) or a polynucleotide (f); and a gene containing, as a coding region, a polynucleotide (g) or a polynucleotide (h); and
(3) at least one of: a gene containing, as a coding region, a polynucleotide (i) or a polynucleotide (j); and a gene containing, as a coding region, a polynucleotide (k) or a polynucleotide (l); and
(C) determining that a tobacco plant, in which the mutation has been detected, is a tobacco plant in which the development of the primary axillary buds is suppressed,
the polynucleotide (a) being a polynucleotide encoding a polypeptide having a sequence identity of 90% or higher with an amino acid sequence represented by SEQ ID NO: 1,
the polynucleotide (b) being a polynucleotide complementary to a polynucleotide which hybridizes with the polynucleotide (a) under stringent conditions,
the polynucleotide (c) being a polynucleotide encoding a polypeptide having a sequence identity of 90% or higher with an amino acid sequence represented by SEQ ID NO: 2,
the polynucleotide (d) being a polynucleotide complementary to a polynucleotide which hybridizes with the polynucleotide (c) under stringent conditions,
the polynucleotide (e) being a polynucleotide encoding a polypeptide having a sequence identity of 90% or higher with an amino acid sequence represented by SEQ ID NO: 3,
the polynucleotide (f) being a polynucleotide complementary to a polynucleotide which hybridizes with the polynucleotide (e) under stringent conditions,
the polynucleotide (g) being a polynucleotide encoding a polypeptide having a sequence identity of 90% or higher with an amino acid sequence represented by SEQ ID NO: 4,
the polynucleotide (h) being a polynucleotide complementary to a polynucleotide which hybridizes with the polynucleotide (g) under stringent conditions,
the polynucleotide (i) being a polynucleotide encoding a polypeptide having a sequence identity of 90% or higher with an amino acid sequence represented by SEQ ID NO: 5,
the polynucleotide (j) being a polynucleotide complementary to a polynucleotide which hybridizes with the polynucleotide (i) under stringent conditions,
the polynucleotide (k) being a polynucleotide encoding a polypeptide having a sequence identity of 90% or higher with an amino acid sequence represented by SEQ ID NO: 6, and
the polynucleotide (l) being a polynucleotide complementary to a polynucleotide which hybridizes with the polynucleotide (k) under stringent conditions.

### Claim 20 (depends on 19)

A method of breeding a tobacco plant, comprising the step of:
crossing the tobacco plants which are determined by the method according to claim 19 as tobacco plants in which development of primary axillary buds is suppressed.

### Claim 21 (depends on 1)

An offspring or a bred progeny, wherein:
the offspring is of the tobacco plant according to claim 1, and
the bred progeny is obtained by crossing the tobacco plant according to claim 1.

### Claim 22 (depends on 12)

An offspring or a bred progeny, wherein:
the offspring is of the tobacco plant produced by the method according to claim 12 and
the bred progeny is obtained by crossing the tobacco plant produced by the method according to claim 12.

### Claim 23 (depends on 19)

An offspring or a bred progeny, wherein:
the offspring is of the tobacco plant determined by the method according to claim 19 and
the bred progeny is obtained by crossing the tobacco plant determined by the method according to claim 19.

### Claim 24 (depends on 20)

An offspring or a bred progeny, wherein:
the offspring is of the tobacco plant bred by the method according to claim 20 and
the bred progeny is obtained by crossing the tobacco plant bred by the method according to claim 20.

### Claim 25 (depends on 1)

A leaf tobacco harvested from the tobacco plant according to claim 1.

### Claim 26 (depends on 12)

A leaf tobacco harvested from the tobacco plant produced by the method according to claim 12.

### Claim 27 (depends on 19)

A leaf tobacco harvested from the tobacco plant determined by the method according to claim 19.

### Claim 28 (depends on 20)

A leaf tobacco harvested from the tobacco plant obtained by the method according to claim 20.

### Claim 29 (depends on 21)

A leaf tobacco harvested from the offspring or the bred progeny according to claim 21.

### Claim 30 (depends on 25)

A cured tobacco obtained from the leaf tobacco according to claim 25.

### Claim 31 (depends on 26)

A cured tobacco obtained from the leaf tobacco according to claim 26.

### Claim 32 (depends on 27)

A cured tobacco obtained from the leaf tobacco according to claim 27.

### Claim 33 (depends on 28)

A cured tobacco obtained from the leaf tobacco according to claim 28.

### Claim 34 (depends on 29)

A cured tobacco obtained from the leaf tobacco according to claim 29.

### Claim 35 (depends on 30)

A tobacco product obtained from the cured tobacco according to claim 30.

### Claim 36 (depends on 31)

A tobacco product obtained from the cured tobacco according to claim 31.

### Claim 37 (depends on 32)

A tobacco product obtained from the cured tobacco according to claim 32.

### Claim 38 (depends on 33)

A tobacco product obtained from the cured tobacco according to claim 33.

### Claim 39 (depends on 34)

A tobacco product obtained from the cured tobacco according to claim 34.
